EcoDrugPlus

Somatostatin Receptor 1

Ensembl ID : ENSCMIG00000002378
Gene Symbol: SSTR1
4 Cross references
160 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSCMIG00000009055
Gene Symbol: SSTR4
1 Cross references
254 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSCMIG00000015976
Gene Symbol: SSTR5
1 Cross references
257 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSCMIG00000011783
Gene Symbol: S1PR1
4 Cross references
194 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSCMIG00000012281
Gene Symbol: SYK
4 Cross references
203 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase-Like

Ensembl ID : ENSCMIG00000016341
Gene Symbol: LOC103177103
4 Cross references
211 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSCMIG00000019153
Gene Symbol: SRD5A2
3 Cross references
266 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSCMIG00000016631
Gene Symbol: SOAT1
4 Cross references
211 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSCMIG00000011119
Gene Symbol: SNCA
4 Cross references
189 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSCMIG00000018849
Gene Symbol: TACR2
3 Cross references
197 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSCMIG00000019682
Gene Symbol: TERT
3 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSCMIG00000019887
Gene Symbol: TBXAS1
4 Cross references
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).